{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T02:44:42Z","timestamp":1785465882667,"version":"3.56.0"},"reference-count":51,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,6,26]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>In VWD (p.V1316M) type 2B, the VWF\u2013GPIb interaction alters the sustained PKC-mediated pathway of Rap1 activation. VWF\/p.V1316M expression in mice causes multiple platelet dysfunctions, including significant ADAM17-independent shedding of GPIb\u03b1.<\/jats:p>","DOI":"10.1182\/bloodadvances.2017014290","type":"journal-article","created":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T15:55:30Z","timestamp":1529510130000},"page":"1417-1428","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":12,"title":["Protein kinase C signaling dysfunction in von Willebrand disease (p.V1316M) type 2B platelets"],"prefix":"10.1182","volume":"2","author":[{"given":"Caterina","family":"Casari","sequence":"first","affiliation":[{"name":"McAllister Heart Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC;"},{"name":"INSERM Unit\u00e9 Mixte de Recherche Scientifique 1176, University Paris-Sud, University Paris-Saclay, Le Kremlin-Bic\u00eatre, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Paul","sequence":"additional","affiliation":[{"name":"McAllister Heart Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Susen","sequence":"additional","affiliation":[{"name":"Hematology Department, University Hospital, Lille-II University, Lille, France,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Lavenu-Bombled","sequence":"additional","affiliation":[{"name":"INSERM Unit\u00e9 Mixte de Recherche Scientifique 1176, University Paris-Sud, University Paris-Saclay, Le Kremlin-Bic\u00eatre, France;"},{"name":"Service d\u2019H\u00e9matologie Biologique, Assistance Publique\u2013H\u00f4pitaux de Paris, Le Kremlin-Bic\u00eatre, France,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Harroche","sequence":"additional","affiliation":[{"name":"Department of Haematology, Haemophilia Care Centre, H\u00f4pital Universitaire Necker-Enfants Malades, Universit\u00e9 Paris Descartes, Sorbonne Paris Cit\u00e9, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Piatt","sequence":"additional","affiliation":[{"name":"McAllister Heart Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn O.","family":"Poe","sequence":"additional","affiliation":[{"name":"McAllister Heart Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Lee","sequence":"additional","affiliation":[{"name":"McAllister Heart Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijke","family":"Bryckaert","sequence":"additional","affiliation":[{"name":"INSERM Unit\u00e9 Mixte de Recherche Scientifique 1176, University Paris-Sud, University Paris-Saclay, Le Kremlin-Bic\u00eatre, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier D.","family":"Christophe","sequence":"additional","affiliation":[{"name":"INSERM Unit\u00e9 Mixte de Recherche Scientifique 1176, University Paris-Sud, University Paris-Saclay, Le Kremlin-Bic\u00eatre, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Lenting","sequence":"additional","affiliation":[{"name":"INSERM Unit\u00e9 Mixte de Recherche Scientifique 1176, University Paris-Sud, University Paris-Saclay, Le Kremlin-Bic\u00eatre, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile V.","family":"Denis","sequence":"additional","affiliation":[{"name":"INSERM Unit\u00e9 Mixte de Recherche Scientifique 1176, University Paris-Sud, University Paris-Saclay, Le Kremlin-Bic\u00eatre, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Bergmeier","sequence":"additional","affiliation":[{"name":"McAllister Heart Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC;"},{"name":"Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2018,6,20]]},"reference":[{"issue":"23","key":"2019111617540930300_B1","doi-asserted-by":"crossref","first-page":"4870","DOI":"10.1182\/blood-2009-11-254193","article-title":"Mutation and ADAMTS13-dependent modulation of disease severity in a mouse model for von Willebrand disease type 2B","volume":"115","author":"Rayes","year":"2010","journal-title":"Blood"},{"issue":"3","key":"2019111617540930300_B2","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1182\/blood-2008-04-152280","article-title":"Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients","volume":"113","author":"Federici","year":"2009","journal-title":"Blood"},{"issue":"5","key":"2019111617540930300_B3","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1055\/s-0036-1579638","article-title":"Type 2B von Willebrand disease: a matter of plasma plus platelet abnormality","volume":"42","author":"Castaman","year":"2016","journal-title":"Semin Thromb Hemost"},{"issue":"12","key":"2019111617540930300_B4","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1172\/JCI69458","article-title":"von Willebrand factor mutation promotes thrombocytopathy by inhibiting integrin \u03b1IIb\u03b23","volume":"123","author":"Casari","year":"2013","journal-title":"J Clin Invest"},{"issue":"15","key":"2019111617540930300_B5","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1182\/blood-2012-04-416594","article-title":"The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways","volume":"120","author":"Burkhart","year":"2012","journal-title":"Blood"},{"issue":"2","key":"2019111617540930300_B6","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/emboj\/16.2.252","article-title":"Rapid Ca2+-mediated activation of Rap1 in human platelets","volume":"16","author":"Franke","year":"1997","journal-title":"EMBO J"},{"key":"2019111617540930300_B7","doi-asserted-by":"crossref","first-page":"412089","DOI":"10.1155\/2012\/412089","article-title":"The small GTPase Rap1b: a bidirectional regulator of platelet adhesion receptors","volume":"2012","author":"Guidetti","year":"2012","journal-title":"J Signal Transduct"},{"issue":"3","key":"2019111617540930300_B8","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1172\/JCI22973","article-title":"Rap1b is required for normal platelet function and hemostasis in mice","volume":"115","author":"Chrzanowska-Wodnicka","year":"2005","journal-title":"J Clin Invest"},{"issue":"28","key":"2019111617540930300_B9","doi-asserted-by":"crossref","first-page":"25715","DOI":"10.1074\/jbc.M202791200","article-title":"Relationships between Rap1b, affinity modulation of integrin alpha IIbbeta 3, and the actin cytoskeleton","volume":"277","author":"Bertoni","year":"2002","journal-title":"J Biol Chem"},{"issue":"12","key":"2019111617540930300_B10","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1182\/blood-2009-04-218768","article-title":"CalDAG-GEFI is at the nexus of calcium-dependent platelet activation","volume":"114","author":"Stefanini","year":"2009","journal-title":"Blood"},{"issue":"4","key":"2019111617540930300_B11","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1172\/JCI77993","article-title":"RASA3 is a critical inhibitor of RAP1-dependent platelet activation","volume":"125","author":"Stefanini","year":"2015","journal-title":"J Clin Invest"},{"issue":"5","key":"2019111617540930300_B12","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1182\/blood-2008-02-139733","article-title":"CalDAG-GEFI and protein kinase C represent alternative pathways leading to activation of integrin alphaIIbbeta3 in platelets","volume":"112","author":"Cifuni","year":"2008","journal-title":"Blood"},{"issue":"3","key":"2019111617540930300_B13","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1538-7836.2009.03722.x","article-title":"Diverse functions of protein kinase C isoforms in platelet activation and thrombus formation","volume":"8","author":"Harper","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2019111617540930300_B14","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1182\/blood.V83.3.691.691","article-title":"Glycocalicin: a new assay--the normal plasma levels and its potential usefulness in selected diseases","volume":"83","author":"Beer","year":"1994","journal-title":"Blood"},{"issue":"3","key":"2019111617540930300_B15","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1182\/blood.V95.3.886.003k45_886_893","article-title":"Structural and functional characterization of the mouse von Willebrand factor receptor GPIb-IX with novel monoclonal antibodies","volume":"95","author":"Bergmeier","year":"2000","journal-title":"Blood"},{"issue":"7","key":"2019111617540930300_B16","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/01.RES.0000143899.73453.11","article-title":"Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates GPIbalpha shedding from platelets in vitro and in vivo","volume":"95","author":"Bergmeier","year":"2004","journal-title":"Circ Res"},{"issue":"7","key":"2019111617540930300_B17","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1111\/j.1538-7836.2007.02590.x","article-title":"Controlled shedding of platelet glycoprotein (GP)VI and GPIb-IX-V by ADAM family metalloproteinases","volume":"5","author":"Gardiner","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2019111617540930300_B18","doi-asserted-by":"crossref","first-page":"H2128","DOI":"10.1152\/ajpheart.00107.2009","article-title":"Shear-induced interaction of platelets with von Willebrand factor results in glycoprotein Ibalpha shedding","volume":"297","author":"Cheng","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"2019111617540930300_B19","doi-asserted-by":"crossref","first-page":"e17168","DOI":"10.1371\/journal.pone.0017168","article-title":"PKC\u03b1 and PKC\u03b4 regulate ADAM17-mediated ectodomain shedding of heparin binding-EGF through separate pathways","volume":"6","author":"Kveiborg","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"2019111617540930300_B20","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1083\/jcb.200310024","article-title":"Cell-matrix interaction via CD44 is independently regulated by different metalloproteinases activated in response to extracellular Ca(2+) influx and PKC activation","volume":"165","author":"Nagano","year":"2004","journal-title":"J Cell Biol"},{"issue":"6","key":"2019111617540930300_B21","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1182\/blood-2002-03-0997","article-title":"Amelioration of the macrothrombocytopenia associated with the murine Bernard-Soulier syndrome","volume":"100","author":"Kanaji","year":"2002","journal-title":"Blood"},{"issue":"9","key":"2019111617540930300_B22","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/nm1098","article-title":"CalDAG-GEFI integrates signaling for platelet aggregation and thrombus formation [published correction appears in Nat Med. 2004;10(10):1139]","volume":"10","author":"Crittenden","year":"2004","journal-title":"Nat Med"},{"issue":"10","key":"2019111617540930300_B23","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1111\/j.1538-7836.2011.04474.x","article-title":"Relative contributions of stromal interaction molecule 1 and CalDAG-GEFI to calcium-dependent platelet activation and thrombosis","volume":"9","author":"Ahmad","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2019111617540930300_B24","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/ATVBAHA.111.239194","article-title":"Rap1-Rac1 circuits potentiate platelet activation","volume":"32","author":"Stefanini","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"13","key":"2019111617540930300_B25","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1084\/jem.20071800","article-title":"Talin is required for integrin-mediated platelet function in hemostasis and thrombosis","volume":"204","author":"Petrich","year":"2007","journal-title":"J Exp Med"},{"issue":"1","key":"2019111617540930300_B26","doi-asserted-by":"crossref","first-page":"26306","DOI":"10.1038\/srep26306","article-title":"A genetically-engineered von Willebrand disease type 2B mouse model displays defects in hemostasis and inflammation","volume":"6","author":"Adam","year":"2016","journal-title":"Sci Rep"},{"issue":"16","key":"2019111617540930300_B27","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1182\/blood-2013-03-493312","article-title":"Accelerated uptake of VWF\/platelet complexes in macrophages contributes to VWD type 2B-associated thrombocytopenia","volume":"122","author":"Casari","year":"2013","journal-title":"Blood"},{"issue":"23","key":"2019111617540930300_B28","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1182\/blood-2009-11-253120","article-title":"Mutation-specific hemostatic variability in mice expressing common type 2B von Willebrand disease substitutions","volume":"115","author":"Golder","year":"2010","journal-title":"Blood"},{"issue":"3","key":"2019111617540930300_B29","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/jth.12802","article-title":"Novel mouse hemostasis model for real-time determination of bleeding time and hemostatic plug composition","volume":"13","author":"Getz","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"8","key":"2019111617540930300_B30","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1182\/blood-2006-03-009449","article-title":"Impaired megakaryocytopoiesis in type 2B von Willebrand disease with severe thrombocytopenia","volume":"108","author":"Nurden","year":"2006","journal-title":"Blood"},{"issue":"19","key":"2019111617540930300_B31","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1056\/NEJM198005083021902","article-title":"Heightened interaction between platelets and factor VIII\/von Willebrand factor in a new subtype of von Willebrand\u2019s disease","volume":"302","author":"Ruggeri","year":"1980","journal-title":"N Engl J Med"},{"issue":"3","key":"2019111617540930300_B32","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1172\/JCI114775","article-title":"Distinct abnormalities in the interaction of purified types IIA and IIB von Willebrand factor with the two platelet binding sites, glycoprotein complexes Ib-IX and IIb-IIIa","volume":"86","author":"De Marco","year":"1990","journal-title":"J Clin Invest"},{"issue":"9","key":"2019111617540930300_B33","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1182\/blood-2003-10-3664","article-title":"Signaling through GP Ib-IX-V activates alpha IIb beta 3 independently of other receptors","volume":"103","author":"Kasirer-Friede","year":"2004","journal-title":"Blood"},{"issue":"35","key":"2019111617540930300_B34","doi-asserted-by":"crossref","first-page":"32880","DOI":"10.1074\/jbc.M302333200","article-title":"Signaling role for phospholipase C gamma 2 in platelet glycoprotein Ib alpha calcium flux and cytoskeletal reorganization. Involvement of a pathway distinct from FcR gamma chain and Fc gamma RIIA","volume":"278","author":"Mangin","year":"2003","journal-title":"J Biol Chem"},{"issue":"1","key":"2019111617540930300_B35","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1182\/blood.V80.1.113.113","article-title":"Shear stress-induced von Willebrand factor binding to platelet glycoprotein Ib initiates calcium influx associated with aggregation","volume":"80","author":"Chow","year":"1992","journal-title":"Blood"},{"issue":"1","key":"2019111617540930300_B36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00109-015-1346-3","article-title":"RAP1-GTPase signaling and platelet function","volume":"94","author":"Stefanini","year":"2016","journal-title":"J Mol Med (Berl)"},{"issue":"12","key":"2019111617540930300_B37","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1182\/blood-2003-04-1305","article-title":"Metalloproteinase inhibitors improve the recovery and hemostatic function of in vitro-aged or -injured mouse platelets","volume":"102","author":"Bergmeier","year":"2003","journal-title":"Blood"},{"issue":"2","key":"2019111617540930300_B38","first-page":"908","article-title":"Platelet ITAM signaling is critical for vascular integrity in inflammation","volume":"123","author":"Boulaftali","year":"2013","journal-title":"J Clin Invest"},{"issue":"suppl 1","key":"2019111617540930300_B39","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.thromres.2014.03.002","article-title":"Adoptive transfer method to study platelet function in mouse models of disease","volume":"133","author":"Bergmeier","year":"2014","journal-title":"Thromb Res"},{"issue":"24","key":"2019111617540930300_B40","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1182\/blood-2012-10-461459","article-title":"Only severe thrombocytopenia results in bleeding and defective thrombus formation in mice","volume":"121","author":"Morowski","year":"2013","journal-title":"Blood"},{"issue":"5","key":"2019111617540930300_B41","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1172\/JCI115468","article-title":"von Willebrand factor binding to platelet GpIb initiates signals for platelet activation","volume":"88","author":"Kroll","year":"1991","journal-title":"J Clin Invest"},{"key":"2019111617540930300_B42","doi-asserted-by":"crossref","first-page":"12863","DOI":"10.1038\/ncomms12863","article-title":"Platelet clearance via shear-induced unfolding of a membrane mechanoreceptor","volume":"7","author":"Deng","year":"2016","journal-title":"Nat Commun"},{"issue":"2","key":"2019111617540930300_B43","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1055\/s-0037-1614447","article-title":"Post-DDAVP thrombocytopenia in type 2B von Willebrand disease is not associated with platelet consumption: failure to demonstrate glycocalicin increase or platelet activation","volume":"81","author":"Casonato","year":"1999","journal-title":"Thromb Haemost"},{"issue":"17","key":"2019111617540930300_B44","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1056\/NEJM198710223171701","article-title":"Plasma glycocalicin. An aid in the classification of thrombocytopenic disorders","volume":"317","author":"Steinberg","year":"1987","journal-title":"N Engl J Med"},{"issue":"2","key":"2019111617540930300_B45","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.abb.2010.01.003","article-title":"The role of calpain in the regulation of ADAM17-dependent GPIbalpha ectodomain shedding","volume":"495","author":"Wang","year":"2010","journal-title":"Arch Biochem Biophys"},{"issue":"2","key":"2019111617540930300_B46","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1182\/blood.V74.2.715.715","article-title":"Montreal platelet syndrome: a defect in calcium-activated neutral proteinase (calpain)","volume":"74","author":"Okita","year":"1989","journal-title":"Blood"},{"issue":"14","key":"2019111617540930300_B47","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1182\/blood-2008-06-165233","article-title":"The Montreal platelet syndrome kindred has type 2B von Willebrand disease with the VWF V1316M mutation","volume":"113","author":"Jackson","year":"2009","journal-title":"Blood"},{"issue":"4","key":"2019111617540930300_B48","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1074\/jbc.M306960200","article-title":"Differential role of protein kinase C delta isoform in agonist-induced dense granule secretion in human platelets","volume":"279","author":"Murugappan","year":"2004","journal-title":"J Biol Chem"},{"issue":"12","key":"2019111617540930300_B49","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1182\/blood-2017-06-742692","article-title":"How I treat type 2B von Willebrand disease","volume":"131","author":"Kruse-Jarres","year":"2018","journal-title":"Blood"},{"issue":"1","key":"2019111617540930300_B50","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/pbc.26168","article-title":"Management of type 2b von Willebrand disease in the neonatal period","volume":"64","author":"Proud","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"2019111617540930300_B51","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/cyto.10114","article-title":"Flow cytometric detection of activated mouse integrin alphaIIbbeta3 with a novel monoclonal antibody","volume":"48","author":"Bergmeier","year":"2002","journal-title":"Cytometry"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/12\/1417\/881086\/advances014290.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/12\/1417\/881086\/advances014290.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T22:54:37Z","timestamp":1573944877000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/2\/12\/1417\/15898\/Protein-kinase-C-signaling-dysfunction-in-von"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,20]]},"references-count":51,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,6,26]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2017014290","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,20]]}}}